Skip to content

Trial · Interventional

CompletedPhase 1Registry data

Adrenal Responsiveness During the Perioperative Period in Children Undergoing Congenital Cardiac Surgery

Overview

Status
Completed
Phase
Phase 1
Enrollment
35 participants (actual)
Sponsor
Mayo Clinic · Other
Design
Allocation not applicable · Open label (no masking)
Countries
1 country

United States

Start
Mar 2009
Primary completion
Jun 2013
Completion
Jun 2013
First posted
25 Apr 2013 (estimated)
Last update posted
16 Jun 2014 (estimated)
Conditions
Adrenal Cortex Diseases · Infant Morbidity

Timeline

1 trial · 1 completed

  • Completed
  • Ongoing
  • Not yet recruiting
  • Stopped
  • Estimated dates (est.)
  • Results posted
200920102011201220132014
  1. Ph 1

    Adrenal Responsiveness During the Perioperative Period in Children Undergoing Congenital Cardiac Surgery

    NCT01839812

    Mar 2009 to Jun 2013

Registry summary

Text and fields below are the sponsor's entries at ClinicalTrials.gov, shown as posted.

Our objective was to determine whether a standard 1mg/kg intraoperative dose of dexamethasone results in similar drug levels for all patients and to characterize the relationship between these drug levels and the innate stress response following infant Cardiopulmonary Bypass (CPB). The investigators hypothesized that postoperative dexamethasone levels are highly variable, and that the infant stress response is inversely related to the amount of dexamethasone measured in the blood. To test this theory the investigators simultaneously measured blood levels of dexamethasone and cortisol at critical time points during the perioperative period for infants undergoing CPB for CHD surgery.

Interventions

  • CosyntropinDrug

Arms1

  • Other

    cosyntropin stimulation test

    All patients enrolled in the study are administered cosyntropin stimulation tests to assess their adrenal response.

Primary outcomes1

Outcomes the sponsor listed as primary.

  1. Cortisol level

    Time frame · 24 hours after surgery

    Registry description

    Primary outcome measure is the cortisol level for each patient at 7 time points throughout the operation and first 24 post-operative hours. Dexamethasone level of the patient is compared with the cortisol level.

Posted results

Values are shown as posted at ClinicalTrials.gov, with their units. PepBank has not converted, pooled or compared them.

No results are posted for this trial.

Completed trials do not always post results.

Registry data comes from ClinicalTrials.gov. Study results come from studies, not from the registry. How PepBank works

Studies0

Studies that cite this trial.

No study cites this trial.

Eligibility

Who could join, as posted.

Sex
All
Age
up to 365 Days
Healthy volunteers
Not accepted
Inclusion and exclusion criteria, as posted
Inclusion Criteria: * less than 365 days of age * Congenital cardiac surgery that requires cardiopulmonary bypass Exclusion Criteria: * Corticosteroids within 24 hours prior to enrollment * Less than 36 weeks gestational age at time of surgery * pre-operative mechanical circulatory support (ECMO)

PepBank is a research reference. Talk to a doctor before you use any peptide.